"We all know friends and family members that have suffered with serious illness. It can be devastating. My goal, alongside my colleagues, is to discover agents that will treat these patients. The motto "patients are waiting" really hits home with everyone."
I was drawn to join Genentech, in 2006, because of its reputation for doing excellent science and employing strong teamwork. At Genentech, any team member with a compelling idea gets a chance to be heard and access to the resources to move their idea forward. The organization is also very nimble and open-minded to incorporate processes to accelerate discovery and development.
Today, I am Senior Vice President of Small Molecule Drug Discovery. In this role I oversee a highly talented and experienced group of multidisciplinary scientists working to generate the next generation of new medicines for patients in need.
What excites me the most is that, at Genentech, we have the brightest people, newest tools, and lots of know-how to continue to make huge strides in solving complex biological and medical issues. It is a huge opportunity and responsibility to shape the future treatments for patients in need.
Journal of Medicinal Chemistry, ISSN: 00222623
Ensuring that we have a culture that supports innovation and provides access to the most cutting-edge approaches and tools is key. Just as important is that we continue to recruit and retain the brightest scientists on the planet.